Anzeige
Mehr »
Donnerstag, 05.06.2025 - Börsentäglich über 12.000 News
Kupfer wird knapp! Jetzt mischen sich Medien ein - und ein Explorer liefert die Story zur Fantasie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A415CY | ISIN: US76090R4083 | Ticker-Symbol: 24O0
NASDAQ
04.06.25 | 21:55
4,755 US-Dollar
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
RESHAPE LIFESCIENCES INC Chart 1 Jahr
5-Tage-Chart
RESHAPE LIFESCIENCES INC 5-Tage-Chart

Aktuelle News zur RESHAPE LIFESCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiWhy ReShape Lifesciences Stock Is Soaring Today: Key Drivers Behind Weight-Loss Company's Surge1
DiReShape Lifesciences achieves EU and UK medical device certification6
DiReShape Lifesciences Inc: ReShape Lifesciences Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio134IRVINE, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that its Quality...
► Artikel lesen
28.05.ReShape Lifesciences Inc. - 8-K, Current Report3
RESHAPE LIFESCIENCES Aktie jetzt für 0€ handeln
21.05.ReShape Lifesciences GAAP EPS of -$18.98, revenue of $1.1M2
21.05.ReShape Lifesciences Inc: ReShape Lifesciences Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update4
20.05.ReShape Lifesciences Inc. - 10-Q, Quarterly Report1
09.05.ReShape Lifesciences Inc. - S-4/A, Registration of securities, business combinations3
07.05.ReShape Lifesciences announces 1-for-25 reverse stock split2
07.05.ReShape Lifesciences kündigt Aktienzusammenlegung im Verhältnis 1:25 an5
07.05.ReShape Lifesciences Inc: ReShape Lifesciences Announces 1-for-25 Reverse Stock Split616IRVINE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that its Board...
► Artikel lesen
02.05.ReShape Lifesciences reveals diabetes device with no heart risk3
02.05.ReShape Lifesciences enthüllt Diabetes-Gerät ohne Herzrisiko4
02.05.ReShape Lifesciences Inc: ReShape Lifesciences Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium5
28.04.ReShape Lifesciences secures patent for intragastric balloon2
28.04.ReShape Lifesciences Inc: ReShape Lifesciences Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System389IRVINE, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that the company...
► Artikel lesen
21.04.ReShape Lifesciences Inc. - 8-K, Current Report1
21.04.ReShape Lifesciences skyrockets after receiving U.S. patent for diabetes neuromodulation technology3
21.04.ReShape Lifesciences Inc: ReShape Lifesciences Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology176Vagal Neuromodulation Offers a Novel Approach to Treating Type 2 Diabetes and Hypoglycemia Patent Enables Equivalent Efficacy with 10 times Lower Energy Consumption Than Current Device Fully Compatible...
► Artikel lesen
10.04.Why ReShape Lifesciences Shares Are Trading Higher By Over 82%; Here Are 20 Stocks Moving Premarket3
Seite:  Weiter >>
48 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1